Cargando…

Efficacy and Safety Evaluation of Mometasone Furoate in Treating Ocular Inflammation

Mometasone furoate (MF) is a medium-potency synthetic glucocorticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. However, its role in the treatment of ocular inflammation has not yet been explored. This work investigated the anti-inflammatory activity of MF in ocular...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lage, Nayara Almeida, de Paiva, Mayara Rodrigues Brandão, Vasconcelos-Santos, Daniel Vitor, Machado, Renes Resende, Fialho, Sílvia Ligório, Silva-Cunha, Armando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9863942/ https://www.ncbi.nlm.nih.gov/pubmed/36678822 http://dx.doi.org/10.3390/pharmaceutics15010193

Ejemplares similares

Efficacy of mometasone furoate and fluticasone furoate on persistent allergic rhinoconjunctivitis
por: Aneeza, W. Hamizan, et al.
Publicado: (2013)

Mometasone furoate in the management of asthma: a review
por: Tan, Ricardo A, et al.
Publicado: (2008)

Clinical outcomes of intravitreal treatment for ocular toxoplasmosis: systematic review and meta-analysis
por: de Melo, Lutiana Amaral, et al.
Publicado: (2023)

Effectiveness of 0.1% mometasone furoate under hydrocolloid dressing versus 0.1% mometasone furoate in patients with lichen simplex chronicus
por: Lo, Hiu Lai, et al.
Publicado: (2023)

Mometasone furoate nasal spray: a systematic review
por: Passali, Desiderio, et al.
Publicado: (2016)

Mometasone furoate is not superior to saline for chronic rhinitis in the elderly
por: Carvalho, Victor, et al.
Publicado: (2019)

Nasal Absorption Enhancement of Mometasone Furoate Nanocrystal Dispersions
por: Masuda, Shuya, et al.
Publicado: (2023)

Zein nanoparticles as oral carrier for mometasone furoate delivery
por: Zimath, Priscila, et al.
Publicado: (2023)

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease
por: Kosoglou, Teddy, et al.
Publicado: (2013)

Development of simple and fast UV-method for the quantitative determination of mometasone furoate in a large number of metered doses of an aqueous nasal spray of mometasone furoate
por: Levin, Mykhaylo, et al.
Publicado: (2019)

Suppression of Cytokine Release by Fluticasone Furoate vs. Mometasone Furoate in Human Nasal Tissue Ex-Vivo
por: Zhang, Nan, et al.
Publicado: (2014)

A patient preference study that evaluated fluticasone furoate and mometasone furoate nasal sprays for allergic rhinitis
por: Yanez, Anahi, et al.
Publicado: (2016)

Mometasone furoate and fluticasone furoate are equally effective in restoring nasal epithelial barrier dysfunction in allergic rhinitis
por: Doulaptsi, Maria, et al.
Publicado: (2021)

Significant receptor affinities of metabolites and a degradation product of mometasone furoate
por: Valotis, Anagnostis, et al.
Publicado: (2004)

One-year treatment with mometasone furoate in chronic obstructive pulmonary disease
por: Calverley, Peter MA, et al.
Publicado: (2008)

Development and evaluation of solid lipid nanoparticles of mometasone furoate for topical delivery
por: Madan, Jyotsana R, et al.
Publicado: (2014)

Comparative safety and efficacy of topical mometasone furoate with other topical corticosteroids
por: Spada, Fabrizio, et al.
Publicado: (2018)

Effects of intranasal mometasone furoate on blood pressure in patients with allergic rhinitis
por: Kartal, O., et al.
Publicado: (2018)

New Vehiculation Systems of Mometasone Furoate for the Treatment of Inflammatory Skin Diseases
por: Taléns-Visconti, Raquel, et al.
Publicado: (2022)

TRIPLE COMBINATION OF HYDROQUINONE, TRETINOIN AND MOMETASONE FUROATE WITH GLYCOLIC ACID PEELS IN MELASMA
por: Godse, Kiran V
Publicado: (2009)

Use of tiotropium bromide in an adolescent with adrenal suppression secondary to inhaled mometasone furoate
por: Hanna, Mariam, et al.
Publicado: (2014)

Developing Biodegradable Nanoparticles Loaded with Mometasone Furoate for Potential Nasal Drug Delivery
por: Far, Jumana, et al.
Publicado: (2020)

Mometasone Furoate in Non-Allergic Rhinitis: A Real-Life Italian Study
por: Rizzi, Angela, et al.
Publicado: (2022)

Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma
por: Noonan, Michael, et al.
Publicado: (2009)

Low-dose melittin is safe for intravitreal administration and ameliorates inflammation in an experimental model of uveitis
por: Moreira Castro, Brenda Fernanda, et al.
Publicado: (2022)

Effect of mometasone furoate/formoterol combination therapy on nocturnal awakenings in subjects with persistent asthma
por: Pearlman, David, et al.
Publicado: (2011)

Long-Term Safety of Mometasone Furoate/Formoterol Combination for Treatment of Patients with Persistent Asthma
por: Maspero, Jorge F, et al.
Publicado: (2010)

The efficacy of mometasone furoate for children with asthma: a meta-analysis of randomized controlled trials
por: Song, Yanling, et al.
Publicado: (2020)

Lung Function Normalisation with Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Asthma
por: Chapman, Kenneth R., et al.
Publicado: (2021)

Mometasone furoate in the treatment of mild, moderate, or severe persistent allergic rhinitis: a non-inferiority study (PUMA)()
por: Antila, Martti Anton, et al.
Publicado: (2016)

Inhaled mometasone furoate for the management of refractory oral corticosteroid-dependent asthma: a case report
por: Nsouli, Talal M
Publicado: (2009)

Efficacy and safety of combined medium-dose mometasone furoate/formoterol (MF/F) in persistent asthmatics
por: Nathan, Robert A, et al.
Publicado: (2010)

Assessment of Patient Attitudes About Mometasone Furoate Nasal Spray: The Ease-of-Use Patient Survey
por: Fromer, Leonard M, et al.
Publicado: (2008)

190 Effect of Mometasone Furoate/Formoterol Combination Therapy on Nocturnal Awakenings in Subjects With Persistent Asthma
por: Pearlman, David, et al.
Publicado: (2012)

191 Quality of Life Improvements in Persistent Asthma Subjects Receiving Combined Mometasone Furoate and Formoterol
por: Murphy, Kevin, et al.
Publicado: (2012)

The glucocorticoid mometasone furoate is a novel FXR ligand that decreases inflammatory but not metabolic gene expression
por: Bijsmans, Ingrid T. G. W., et al.
Publicado: (2015)

Efficacy of mometasone furoate for nasal polyps: A protocol for systematic review of randomized controlled trial
por: Yu, Hai-jiang, et al.
Publicado: (2019)

In-office Placement of Mometasone Furoate Sinus Implants for Recurrent Nasal Polyps: A Pooled Analysis
por: Stolovitzky, J. Pablo, et al.
Publicado: (2019)

Asthma control using a combination of mometasone furoate/formoterol: grouped analysis of three clinical trials
por: White, Martha, et al.
Publicado: (2011)

The Clinical Efficacy of Mometasone Furoate in Multi-Lamellar Emulsion for Eczema: A Double-blinded Crossover Study
por: Kim, Duk Han, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_5lh6cd9ips7o6rapril7f5a6us